NasdaqGS - Delayed Quote USD
Agios Pharmaceuticals, Inc. (AGIO)
32.09
+0.25
+(0.79%)
At close: May 30 at 4:00:02 PM EDT
32.09
0.00
(0.00%)
After hours: May 30 at 6:00:44 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BALLAL RAHUL D. Director | Conversion of Exercise of derivative security | Nov 8, 2024 | 7,992 |
| BURNS JAMES WILLIAM Officer | Sale | Mar 3, 2025 | 25,449 |
| FOUSE JACQUALYN A. Director | Sale | Apr 10, 2025 | 149,220 |
| GHEUENS SARAH Officer | Sale | Mar 3, 2025 | 53,897 |
| GOFF BRIAN Chief Executive Officer | Sale | Mar 3, 2025 | 92,345 |
| JONES CECILIA Chief Financial Officer | Sale | Mar 3, 2025 | 25,829 |
| MILANOVA TSVETA Officer | Sale | Mar 3, 2025 | 22,892 |
| SCADDEN DAVID T M.D. Director | Conversion of Exercise of derivative security | Dec 11, 2024 | 15,483 |
| SMITH CYNTHIA Director | Conversion of Exercise of derivative security | Aug 9, 2024 | 7,992 |
| WASHBURN THEODORE JAMES JR Officer | Sale | Mar 3, 2025 | 9,414 |
Related Tickers
RARE Ultragenyx Pharmaceutical Inc.
34.03
-2.85%
PTCT PTC Therapeutics, Inc.
48.52
-0.76%
ENTA Enanta Pharmaceuticals, Inc.
5.93
-3.73%
TVTX Travere Therapeutics, Inc.
15.02
-2.34%
INCY Incyte Corporation
65.06
-1.48%
BPMC Blueprint Medicines Corporation
101.35
-1.66%
STOK Stoke Therapeutics, Inc.
9.54
-1.95%
ZYME Zymeworks Inc.
11.43
+0.70%
OLMA Olema Pharmaceuticals, Inc.
5.28
-0.38%
ANAB AnaptysBio, Inc.
22.23
-1.46%